Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

Author： Frasci Giuseppe   Comella Pasquale   Thomas Renato   Bonito Maurizio   Lapenta Liliana   Capasso Immacolata   Botti Gerardo   Vallone Paolo   Rosa Vincenzo   D'Aiuto Giuseppe   Comella Giuseppe  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.53, Iss.1, 2004-01, pp. : 25-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer

By Hirose Takashi   Shirai Takao   Ishida Hiroo   Ando Kohichi   Sugiyama Tomohide   Kusumoto Sojiro   Hosaka Takamichi   Nakashima Masanao   Ohmori Tohru   Adachi Mitsuru  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 267-274

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer

By Molina Julian   Nikcevich Daniel   Hillman Shauna   Geyer Susan   Drevyanko Timothy   Jett James   Verdirame Joseph   Tazelaar Henry   Rowland Kendrith   Wos Edward   Kutteh Leila   Nair Suresh   Fitch Tom   Flynn Patrick   Stella Philip   Adjei Alex  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 382-389

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

By Oki Yasunari   Hirose Takashi   Yamaoka Toshimitsu   Kusumoto Sojiro   Shirai Takao   Sugiyama Tomohide   Okuda Kentaro   Nakashima Masanao   Murata Yasunori   Ohmori Tohru   Adachi Mitsuru  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 791-797

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

By Tsunoda Toshiyuki   Koizumi Tomonobu   Hayasaka Muneharu   Hirai Kazuya   Koyama Shigeru   Takabayashi Yasuki   Fujimoto Keisaku   Kubo Keishi  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 173-177

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancer

By Kasai T.   Oka M.   Soda H.   Tsurutani J.   Fukuda M.   Nakamura Y.   Kawabata S.   Nakatomi K.   Nagashima S.   Takatani H.   Fukuda M.   Kinoshita A.   Kohno S.  

European Journal of Cancer, Vol. 38, Iss. 14, 2002-09 ,pp. : 1871-1878

Elsevier

Access to resources Recommend Favorite